Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.72 $29,633 - $50,799
70,555 Added 335.96%
91,556 $57,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $6,907 - $17,613
-11,512 Reduced 35.41%
21,001 $12,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $6,181 - $9,595
5,887 Added 22.11%
32,513 $36,000
Q1 2023

May 09, 2023

BUY
$1.2 - $2.73 $16,964 - $38,594
14,137 Added 113.2%
26,626 $35,000
Q4 2022

Feb 10, 2023

SELL
$1.71 - $3.61 $119,154 - $251,548
-69,681 Reduced 84.8%
12,489 $23,000
Q3 2022

Nov 10, 2022

BUY
$1.9 - $8.63 $128,867 - $585,329
67,825 Added 472.81%
82,170 $202,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $17,204 - $72,773
8,077 Added 128.86%
14,345 $35,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $9,671 - $24,008
1,540 Added 32.57%
6,268 $50,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $30,296 - $59,088
2,061 Added 77.28%
4,728 $72,000
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $75,482 - $104,328
-3,105 Reduced 53.79%
2,667 $76,000
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $3.68 Million - $5.7 Million
-141,211 Reduced 96.07%
5,772 $195,000
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $3.8 Million - $6.55 Million
115,028 Added 359.97%
146,983 $5.62 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $754,319 - $1.11 Million
19,297 Added 152.45%
31,955 $1.34 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $106,441 - $167,244
3,744 Added 42.0%
12,658 $549,000
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $104,382 - $270,005
8,914 New
8,914 $270,000
Q4 2019

Feb 07, 2020

SELL
$15.02 - $20.57 $450 - $617
-30 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$18.85 - $27.5 $565 - $825
30 New
30 $1,000
Q1 2019

May 14, 2019

SELL
$10.65 - $25.75 $2,726 - $6,592
-256 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $2,370 - $4,193
256 New
256 $3,000
Q1 2018

May 15, 2018

SELL
$4.69 - $10.05 $5,215 - $11,175
-1,112 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$7.86 - $9.99 $8,740 - $11,108
1,112 New
1,112 $10,000
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $0 - $0
0
0 $0

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.